Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV Open-label Pharmaco-economic and Practice Management Study of a New Preventive Treatment for Adult Caries in the U.K. and Germany
2006-006104-11Phase 4Completed
- Sponsor
- CHX Technologies
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of chlorhexidine acetate in carious lesion, sponsored by CHX Technologies. Primary endpoint: Benefit-cost assessment. Started Jan 2007; status: completed.
02
Drugs
chlorhexidine acetate
03
Conditions
carious lesion
Beyond the preview
Go deeper on 2006-006104-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006104-11.